|
MKLN1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.71085368094737E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.20101714631937E-12 |
| Normal-vs-Stage2 |
4.05239999999862E-05 |
| Normal-vs-Stage3 |
7.85949971771061E-10 |
| Normal-vs-Stage4 |
1.26540000700004E-10 |
| Stage1-vs-Stage2 |
3.216200E-01 |
| Stage1-vs-Stage3 |
3.377400E-01 |
| Stage1-vs-Stage4 |
7.512100E-02 |
| Stage2-vs-Stage3 |
1.622250E-01 |
| Stage2-vs-Stage4 |
4.810500E-02 |
| Stage3-vs-Stage4 |
4.977400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.09068351309361E-13 |
| Normal-vs-AfricanAmerican |
5.778900E-04 |
| Normal-vs-Asian |
1.78269999873137E-08 |
| Caucasian-vs-AfricanAmerican |
3.219600E-01 |
| Caucasian-vs-Asian |
6.732600E-01 |
| AfricanAmerican-vs-Asian |
2.100600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.83446616073024E-12 |
| Normal-vs-Female |
4.7161163863052E-12 |
| Male-vs-Female |
4.257400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.52150522683792E-11 |
| Normal-vs-Age(41-60Yrs) |
5.1854998073253E-10 |
| Normal-vs-Age(61-80Yrs) |
2.13699946627344E-10 |
| Normal-vs-Age(81-100Yrs) |
5.990900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.609600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.203800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.522000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.150400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.044600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.606400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.292460E-02 |
| Classical-VS-Follicular |
6.474600E-01 |
| Classical-VS-Other |
2.122800E-01 |
| Classical-VS-Normal |
2.13390416448078E-11 |
| Tall-VS-Follicular |
8.892400E-02 |
| Tall-VS-Other |
7.609600E-01 |
| Tall-VS-Normal |
6.53689991025885E-10 |
| Follicular-VS-Other |
3.516200E-01 |
| Follicular-VS-Normal |
1.00559999993699E-07 |
| Other-VS-Normal |
1.160240E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.41020569958073E-12 |
| Normal-vs-N1 |
5.3878002059804E-10 |
| N0-vs-N1 |
1.872010E-01 |
|
|
